CLOs on the Move

Sunrise Labs

www.sunriselabs.com

 
Sunrise Labs architects and implements innovative engineering solutions for ‘smart’ products that work. We are a product development company specializing in one-stop delivery of robust, reliable medical devices and industrial instrumentation.Eric, Laurin and Drew In 1992, Drew Sunstein founded our company to partner with clients and produce quality, practical, cost-effective design solutions with a sharp focus on time-to-market. We build products that work. Our products work for the end user, the manufacturer, and all service providers. With experience spanning the development progression, and a reputation for delivering on commitments, our team is the smart choice to tackle your product development challenges. Our engineers design ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

FusionOne

FusionOne is a Roselle, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Renovia Incorporated

Renovia was formed to develop and commercialize products for better first-line diagnosis and treatment to improve the condition-specific quality of life for millions of women with pelvic floor disorders. Renovia`s technology enables treatment via precise visualization of pelvic movement in real-time during pelvic floor muscle training, while monitoring usage and progress over time. As a women`s health organization, Renovia is in pursuit of scalable and cost-effective care for pelvic floor disorders delivered through the power of digital health.

AEIOMED

AEIOMED is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Shared PET imagining

Shared PET imagining is a Canton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Miromatrix Medical

The Miromatrix Medical technology has the potential to enable the creation of fully biological replacement organs for the human body. In addition to the Company’s internal efforts focused on the development of its first product – a biological mesh for hernia repair – scientists around the globe are working with the Company’s technology and are taking critical steps toward the creation of human organs including the liver, lung, kidney, pancreas and heart. While our biological mesh development program has been conducted internally, our intent is for current and future products to be developed both at Miromatrix and in partnership with the best among those external groups already working with our technology in order to utilize this pre-existing expertise to develop individual products in the most efficacious, cost-effective and timely way possible.